The use of repetitive transcranial magnetic stimulation and vagal nerve stimulation in the treatment of depression

Current Opinion in Psychiatry

Volumn 21, Issue 1, 2008, Pages 25-29

  Fitzgerald, Paul B ^a,c   Daskalakis, Zafiris J ^b  

^a MONASH UNIVERSITY   (Australia)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c Australia   (Australia)

Author keywords

Depression; Transcranial magnetic stimulation; Treatment resistance; Treatmentresistant depression; Vagal nerve stimulation

Indexed keywords

DEPRESSION; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL RESEARCH; PATIENT SAFETY; REVIEW; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT PLANNING; TREATMENT RESPONSE; VAGUS NERVE STIMULATION;

AFFECT; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER; DOMINANCE, CEREBRAL; ELECTRIC STIMULATION THERAPY; ELECTROCONVULSIVE THERAPY; HUMANS; PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; VAGUS NERVE;

EID: 40349097938     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3282f15e89     Document Type: Review

References (37)

1. Barker AT. The history and basic principles of magnetic nerve stimulation. Electroencephalogr Clin Neurophysiol Suppl 1999; 51:3-21.
2. Pascual-Leone A, Tormos JM, Keenan J, et al. Study and modulation of human cortical excitability with transcranial magnetic stimulation. J Clin Neurophysiol 1998; 15:333-343.
3. Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol 2006; 117:2584-2596. A detailed review of the effects of rTMS paradigms on brain excitability.
4. Fitzgerald PB, Brown T, Daskalakis ZJ, et al. Intensity-dependent effects of 1 Hz rTMS on human corticospinal excitability. Clin Neurophysiol 2002; 113:1136-1141.
5. Chen R, Seitz RJ. Changing cortical excitability with low-frequency magnetic stimulation. Neurology 2001; 57:379-380.
6. Avery DH, Holtzheimer PE 3rd, Fawaz W, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry 2006; 59:187-194. This paper describes a very well conducted and large single-site trial of high-frequency left-sided rTMS compared with sham. The study found a significant benefit of active treatment but a moderate overall response rate with active stimulation.
7. O'Reardon J, Solvason B, Janicak P, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; Epub ahead of print. This study was the first major registration multisite trial of rTMS conducted. The study provided a very high dose of stimulation and confirms that high-frequency left-sided rTMS has greater effects than sham stimulation, and is generally safe and well tolerated.
8. Fitzgerald PB, Brown T, Marston NAU, et al. A double-blind placebo controlled trial of transcranial magnetic stimulation in the treatment of depression. Arch Gen Psychiatry 2003; 60:1002-1008.
9. Grunhaus L, Dannon PN, Schreiber S, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry 2000; 47:314-324.
10. Janicak PG, Dowd SM, Martis B, et al. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry 2002; 51:659-667.
11. Pridmore S, Bruno R, Turnier-Shea Y, et al. Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. Int J Neuropsychopharmacol 2000; 3:129-134.
12. Eranti S, Mogg A, Pluck G, et al. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 2007; 164:73-81. This randomized controlled trial found a greater degree of response to ECT than to rTMS. Future ECT-rTMS comparisons should provide more equal conditions in the provision of similar flexible or inflexible treatment protocols across the two conditions.
13. Kozel FA, Nahas Z, deBrux C, et al. How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation. J Neuropsychiatry Clin Neurosci 2000; 12:376-384.
14. Rosa MA, Gattaz WF, Pascual-Leone A, et al. Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar nonpsychotic refractory depression: a randomized, single-blind study. Int J Neuropsychopharmacol 2006; 9:667-676. This randomized comparison of left prefrontal rTMS and ECT found similar response rates with both techniques. This is consistent with several pre-existing studies, although there are limits in the way in which rTMS methods are applied in these trials.
15. Loo CK, Mitchell PB, McFarquhar TF, et al. A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression. Psychol Med 2007; 37:341-349. This study showed that twice-daily TMS is more effective than sham, but did not investigate the potential differential effectiveness of daily and twice-daily treatment.
16. Turnier-Shea Y, Bruno R, Pridmore S. Daily and spaced treatment with transcranial magnetic stimulation in major depression: a pilot study. Aust N Z J Psychiatry 2006; 40:759-763. This small study suggests that administering rTMS 5 days a week may not be essential and less-intensive treatment regimes are worthy of investigation.
17. Klein E, Kreinin I, Chistyakov A, et al. Therapeutic efficiency of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double blind controlled trial. Arch Gen Psychiatry 1999; 56:315-320.
18. Januel D, Dumortier G, Verdon CM, et al. A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): therapeutic and cognitive effect in medication free unipolar depression during 4 weeks. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:126-130. This study provides confirmatory data on the effectiveness of low-frequency right-sided rTMS compared with sham stimulation.
19. Fitzgerald PB, Huntsman S, Gunewardene R, et al. A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression. Int J Neuropsychopharmacol 2006; 9:655-666. In this study 130 patients were randomized to either 1 or 2 Hz stimulation applied to the right frontal cortex with left-sided stimulation offered to nonresponders. A significant response rate of greater than 50% was achieved, but there were no between-group differences.
20. Mantovani A, Lisanby SH, Pieraccini F, et al. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. J Affect Disord 2007; 102:277-280.
21. Fitzgerald PB, Benitez J, De Castella A, et al. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 2006; 163:88-94. This study compared a substantive sample of patients randomized to either sequential bilateral rTMS (low-frequency right followed by high-frequency left) or sham. Active stimulation was substantially better than sham, achieved a clinically significant response rate (around 50%) and continued to accumulate benefits across the entire 6 weeks of the study.
22. Garcia-Toro M, Salva J, Daumal J, et al. High (20 Hz) and low (1 Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression. Psychiatry Res 2006; 146:53-57. This innovative study compared bilateral rTMS and a bilateral condition based on single photon emission computed tomography scanning. These were both more effective than sham, but a considerably larger study is required to analyze whether image-based targeting is of clinical value.
23. Rosa MA, Picarelli H, Teixeira MJ, et al. Accidental seizure with repetitive transcranial magnetic stimulation. J ECT 2006; 22:265-266.
24. Anderson B, Mishory A, Nahas Z, et al. Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT 2006; 22:49-53. An interesting publication showing no adverse events with very high doses of stimulation in normal subjects.
25. Marcolin MA, Souza Filho JL, Teixeira MJ, et al. Transient visual changes associated with repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex in cases of major depression. Rev Bras Psiquiatr 2006; 28:251.
26. Xia G, Gajawani P, Muzina D, et al. Treatment-emergent mania in unipolar and bipolar depression: a focus on repetitive transcranial magnetic stimulation. Int J Neuropsychopharmacol 2007; Epub ahead of print A timely review of the incidence of treatment-emergent mania during rTMS treatment.
27. Fitzgerald PB, Oxley TJ, Laird AR, et al. An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Res 2006; 148:33-45.
28. George MS, Sackeim HA, Marangell LB, et al. Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr Clin North Am 2000; 23:757-783.
29. Goodnick PJ, Rush AJ, George MS, et al. Vagus nerve stimulation in depression. Expert Opin Pharmacother 2001; 2:1061-1063.
30. Nemeroff CB, Mayberg HS, Krahl SE, et al. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006; 31:1345-1355. This is a comprehensive review of the effectiveness of VNS and its potential mechanisms of action.
31. Fitzgerald P. A review of developments in brain stimulation and the treatment of psychiatric disorders. Curr Psychiatry Rev 2006; 2:199-205.
32. Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005; 58:347-354.
33. George MS, Rush AJ, Marangell LB, et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005; 58:364-373.
34. Sackeim HA, Brannan SK, John Rush A, et al. Durability of antidepressant response to vagus nerve stimulation (VNS™). Int J Neuropsychopharmacol 2007; Epub ahead of print In this study patients from the original VNS trials were followed over several years and the persistence of clinical response was investigated. The study results suggest that patients who respond to VNS can expect a relatively high likelihood of ongoing substantial clinical benefit.
35. Corcoran CD, Thomas P, Phillips J, et al. Vagus nerve stimulation in chronic treatment-resistant depression: preliminary findings of an open-label study. Br J Psychiatry 2006; 189:282-283. A small open-label study of VNS is notable for the response rate achieved and also the relatively high incidence of significant adverse events.
36. Bodenlos JS, Kose S, Borckardt JJ, et al. Vagus nerve stimulation acutely alters food craving in adults with depression. Appetite 2007; 48:145-153.
37. Burke MJ, Husain MM. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression. J ECT 2006; 22:218-222. This is the first study to indicate the safety of a combination of VNS and ECT treatments.